Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a stroke (either a bleed in the brain or a blockage of blood flow) by a qualified doctor.
- People whose stroke happened within the last three months.
- People whose arm muscle strength is rated at 4 points or below on a standard medical muscle strength scale.
- People with no previous history of stroke, epilepsy, dementia, Parkinson's disease, or other diseases that affect the nervous system over time.
- People who are able to sit upright in a chair for more than 15 minutes.
- People aged 18 or older.
Who may not be able to join:
- People who have had more than one stroke, a brain injury, a brain tumour, a spinal cord injury, Parkinson's disease, or other conditions affecting the muscles or skeleton that could interfere with assessment or treatment.
- People for whom focused ultrasound treatment is not safe, including those who are pregnant, have a pacemaker or other implanted medical device, have certain connective tissue diseases, have blood clotting problems, have implants near or in the brain, or are considered unsuitable by their doctor.
- People who cannot cooperate with treatment or assessments due to reduced consciousness or difficulty with speech, or who are unable to give informed consent.
- People whose skull structure would prevent the ultrasound from passing through to the brain (confirm with trial site).
- People taking blood-thinning medications who also have blood clotting problems based on specific lab results.
- People for whom a CT scan would not be safe or suitable.
- People with major physical illnesses or significant neurological conditions, such as epilepsy or a history of brain surgery.
- People who have any metal implants in their body.
- People currently taking tricyclic antidepressants, certain pain medications, or anti-seizure medications.
- People who experience sleep problems during the ultrasound treatment sessions.
- People with a history of alcohol dependency.
- People with severe or uncontrollable high pressure in the brain.
- People who require ongoing blood-thinning medication.
- People with any growth or abnormal mass inside the skull.
- People whose pre-treatment CT scan shows significant calcium build-up in the blood vessels of the brain.
- People who have wounds or skin damage on the scalp in the area where the treatment would be applied.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Meng Ting Lin, M.D., National Taiwan University Hospital
Phone: +886-2312-3456
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of Treatment-related Adverse Events; Cortical excitability
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.